CXCL10 and type 1 diabetes mellitus: Released CXCL10 in the microenvironment further activates CXCR3 on cytotoxic CD8+ T cells in lymph nodes (LNs) thus initiating the recruitment of cytotoxic T cells into pancreatic islets to potentiate insulitis and T1D progression.